International Normalized Ratio as a Screening Test for Assessment of Anticoagulant Activity for Patients Treated With Rivaroxaban or Apixaban: A Pilot Study

• 主要な著者: Fanny Ofek (著者), Dana Barchel (著者), Nofar Perets (著者), Tomer Ziv-Baran (著者), Ahmad Mahajna (著者), Talia Filipovich-Rimon (著者), Osnat Garach-Jehoshua (著者), Maya Berlin (著者), Matitiahu Berkovitch (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2019-10-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Introduction: In patients treated with direct oral anti activated factor X (anti-FXa) anticoagulants such as apixaban and rivaroxaban, there are several emergency and non-emergency conditions in which anticoagulation activity should be measured. The validity of the common global clotting tests, prot...